The association between anxiety, traumatic stress, and obsessive–compulsive disorders and chronic inflammation: A systematic review and meta-analysis

Depression and Anxiety

Volumn 35, Issue 11, 2018, Pages 1081-1094

  Renna, Megan E ^a   O'Toole, Mia S ^b   Spaeth, Phillip E ^a   Lekander, Mats ^c,d   Mennin, Douglas S ^a  

^a Columbia University ^*  (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

anxiety disorders; biological markers; OCD; PTSD; SAD

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANXIETY; ARTICLE; CHRONIC INFLAMMATION; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; SOCIAL PHOBIA; SYSTEMATIC REVIEW; ANXIETY DISORDER; INFLAMMATION; META ANALYSIS;

ANXIETY DISORDERS; COMORBIDITY; HUMANS; INFLAMMATION; OBSESSIVE-COMPULSIVE DISORDER; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85053038652     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22790     Document Type: Article

References (94)

1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Washington, DC: Author.
2. Baker, D. G., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Zoumakis, E., Dashevsky, B. A., … Geracioti, T. D., Jr (2001). Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation, 9(4), 209–217.
3. Bersani, F. S., Wolkowitz, O. M., Lindqvist, D., Yehuda, R., Flory, J., Bierer, L. M., … Epel, E. S. (2016). Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain, Behavior, and Immunity, 52, 153–160.
4. Brambilla, F., Bellodi, L., & Perna, G. (1999). Plasma levels of tumor necrosis factor-α in patients with panic disorder: Effect of alprazolam therapy. Psychiatry Research, 89(1), 21–27. https://doi.org/10.1016/S0165-1781(99)00091-8
5. Brambilla, F., Bellodi, L., Perna, G., Bertani, A., Panerai, A., & Sacerdote, P. (1994). Plasma interleukin-1 beta concentrations in panic disorder. Psychiatry Research, 54(2), 135–142.
6. Brambilla, F., Perna, G., Bellodi, L., Arancio, C., Bertani, A., Perini, G., … Gava, F. (1997). Plasma interleukin-1β and tumor necrosis factor concentrations in obsessive–compulsive disorders. Biological Psychiatry, 42(11), 976–981.
7. Carleton, R. N. (2012). The intolerance of uncertainty construct in the context of anxiety disorders: Theoretical and practical perspectives. Expert Review of Neurotherapeutics, 12(8), 937–947.
8. Chen, T., Guo, M., Gao, Y., Chen, F., Guo, J., Liu, T., … Jiang, X. (2013). A comparative study on the levels of serum cytokines and cortisol among post-traumatic stress disorder patients of Li and Han ethnicities in Hainan. Chinese Medical Journal, 127(15), 2771–2774.
9. Chung, H. Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A. Y., … Leeuwenburgh, C. (2009). Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Research Reviews, 8(1), 18–30.
10. Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences, 109(16), 5995–5999.
11. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9(1), 46–56.
12. Del Giudice, M., & Gangestad, S. W. (2018). Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain, Behavior, and Immunity, 70, 61–75.
13. Dhabhar, F. S. (2014). Effects of stress on immune function: The good, the bad, and the beautiful. Immunologic Research, 58(2-3), 193–210.
14. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5), 446–457.
15. Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463.
16. Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629–634.
17. Falsetti, S. A., Monnier, J., Davis, J. L., & Resnick, H. S. (2002). Intrusive thoughts in posttraumatic stress disorder. Journal of Cognitive Psychotherapy, 16(2), 127.
18. Festa, A., D'Agostino, R., Jr., Williams, K., Karter, A. J., Mayer-Davis, E. J., Tracy, R. P., & Haffner, S. M. (2001). The relation of body fat mass and distribution to markers of chronic inflammation. International Journal of Obesity and Related Metabolic Disorders, 25(10), 1407–1415.
19. Fontenelle, L. F., Barbosa, I. G., Luna, J. V., de Sousa, L. P., Abreu, M. N. S., & Teixeira, A. L. (2012). A cytokine study of adult patients with obsessive-compulsive disorder. Comprehensive Psychiatry, 53(6), 797–804.
20. Furtado, M., & Katzman, M. A. (2015). Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Research, 229(1), 37–48.
21. Gan, W. Q., Man, S. F. P., Senthilselvan, A., & Sin, D. D. (2004). Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax, 59(7), 574–580.
22. Garcia-Moll, X., Zouridakis, E., Cole, D., & Kaski, J. C. (2000). C-reactive protein in patients with chronic stable angina: Differences in baseline serum concentration between women and men. European Heart Journal, 21(19), 1598–1606.
23. Gill, J., Luckenbaugh, D., Charney, D., & Vythilingam, M. (2010). Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biological Psychiatry, 68(11), 999–1006.
24. Gill, J. M., Saligan, L., Lee, H., Rotolo, S., & Szanton, S. (2013). Women in recovery from PTSD have similar inflammation and quality of life as non-traumatized controls. Journal of Psychosomatic Research, 74(4), 301–306.
25. Gill, J. M., Saligan, L., Woods, S., & Page, G. (2009). PTSD is associated with an excess of inflammatory immune activities. Perspectives in Psychiatric Care, 45(4), 262–277.
26. Gill, J., Vythilingam, M., & Page, G. G. (2008). Low cortisol, high DHEA, and high levels of stimulated TNF-α, and IL-6 in women with PTSD. Journal of Traumatic Stress, 21(6), 530–539.
27. Gola, H., Engler, H., Sommershof, A., Adenauer, H., Kolassa, S., Schedlowski, M., … Kolassa, I. T. (2013). Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry, 13, 1.
28. Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016). A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression. Molecular Psychiatry, 21(12), 1696–1709.
29. Gray, S. M., & Bloch, M. H. (2012). Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Current Psychiatry Reports, 14(3), 220–228.
30. Guo, M., Liu, T., Guo, J. C., Jiang, X. L., Chen, F., & Gao, Y. S. (2012). Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pacific Journal of Tropical Medicine, 5(4), 323–325.
31. Halpin, S. J., & Ford, A. C. (2012). Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis. The American Journal of Gastroenterology, 107(10), 1474–1482.
32. Hayes, S. C., Wilson, K. G., & Gifford, E. V. (2015). Experiential Avoidance and Behavioral Disorders. The Act in Context: The Canonical Papers of Steven C. Hayes, 171.
33. Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. New York, NY: Academic Press.
34. Heikkilä, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., … Lawlor, D. A. (2009). Associations of circulating C-reactive protein and interleukin-6 with cancer risk: Findings from two prospective cohorts and a meta-analysis. Cancer Causes & Control, 20(1), 15–26.
35. Herrán, A., Sierra-Biddle, D., García-Unzueta, M. T., Puente, J., Vázquez-Barquero, J. L., & Amado, J. A. (2005). The acute phase response in panic disorder. International Journal of Neuropsychopharmacology, 8(4), 529–535.
36. Higgins, J., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558.
37. Hoge, E. A., Brandstetter, K., Moshier, S., Pollack, M. H., Wong, K. K., & Simon, N. M. (2009). Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depression and Anxiety, 26(5), 447–455.
38. Hou, R., Garner, M., Holmes, C., Osmond, C., Teeling, J., Lau, L., & Baldwin, D. S. (2017). Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: Case-controlled study. Brain, Behavior, and Immunity, 62, 212–218.
39. Jergović, M., Bendelja, K., Mlakar, A. S., Vojvoda, V., Aberle, N., Jovanovic, T., … Vidović, A. (2015). Circulating levels of hormones, lipids, and immune mediators in post-traumatic stress disorder–a 3-month follow-up study. Frontiers in Psychiatry, 6
40. Jergović, M., Tomičević, M., Vidović, A., Bendelja, K., Savić, A., Vojvoda, V., … Sabioncello, A. (2014). Telomere shortening and immune activity in war veterans with posttraumatic stress disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 54, 275–283.
41. Kaptoge, S., Seshasai, S. R. K., Gao, P., Freitag, D. F., Butterworth, A. S., Borglykke, A., … Jørgensen, T. (2013). Inflammatory cytokines and risk of coronary heart disease: New prospective study and updated meta-analysis. European Heart Journal, 35(9), 578–589.
42. Kibler, J. L., Tursich, M., Ma, M., Malcolm, L., & Greenbarg, R. (2014). Metabolic, autonomic and immune markers for cardiovascular disease in posttraumatic stress disorder. World Journal of Cardiology, 6(6), 455–461.
43. Koh, K. B., & Lee, B. K. (1998). Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosomatic Medicine, 60(4), 479–483.
44. Koh, K. B., & Lee, Y. (2004). Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychotherapy and Psychosomatics, 73(5), 286–292.
45. Kokai, M., Kashiwamura, S. I., Okamura, H., Ohara, K., & Morita, Y. (2002). Plasma interleukin-18 levels in patients with psychiatric disorders. Journal of Immunotherapy, 25, S68–S71.
46. Konuk, N., Tekın, I. O., Ozturk, U., Atik, L., Atasoy, N., Bektas, S., & Erdogan, A. (2007). Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators of Inflammation, 2007, 65704.
47. Kuo, H. K., Yen, C. J., Chang, C. H., Kuo, C. K., Chen, J. H., & Sorond, F. (2005). Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis. The Lancet Neurology, 4(6), 371–380.
48. Lasselin, J., Elsenbruch, S., Lekander, M., Axelsson, J., Karshikoff, B., Grigoleit, J. S., … Benson, S. (2016). Mood disturbance during experimental endotoxemia: Predictors of state anxiety as a psychological component of sickness behavior. Brain, Behavior, and Immunity, 57, 30–37.
49. Light, R. J., Singer, J. D., & Willett, J. B. (1994). The visual presentation and interpretation of meta-analyses. In H. Cooper & L. V. Hedges (Eds.), The handbook of research synthesis (pp. 439–453). New York, NY: Russell Sage Foundation.
50. Lipsey, M. W., & Wilson, D. B. (2001). Practical meta-analysis (Vol. 49). London, England: Sage Publications Inc.
51. Lindqvist, D., Wolkowitz, O. M., Mellon, S., Yehuda, R., Flory, J. D., Henn-Haase, C., … Makotkine, I. (2014). Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain, Behavior, and Immunity, 42, 81–88.
52. Maes, M., Lin, A. H., Delmeire, L., Van Gastel, A., Kenis, G., De Jongh, R., & Bosmans, E. (1999). Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biological Psychiatry, 45(7), 833–839.
53. Maes, M., Meltzer, H. Y., & Bosmans, E. (1994). Psychoimmune investigation in obsessive-compulsive disorder: Assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1β and IL-6 concentrations. Neuropsychobiology, 30(2-3), 57–60.
54. McEvoy, P. M., Watson, H., Watkins, E. R., & Nathan, P. (2013). The relationship between worry, rumination, and comorbidity: Evidence for repetitive negative thinking as a transdiagnostic construct. Journal of Affective Disorders, 151(1), 313–320.
55. Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M. (2005). Preliminary evidence for an emotion dysregulation model of generalized anxiety disorder. Behaviour Research and Therapy, 43(10), 1281–1310.
56. Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017). Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology, 42, 254–270.
57. Miller, G. E., Chen, E., & Zhou, E. S. (2007). If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychological Bulletin, 133(1), 25–45.
58. Miller, R. J., Sutherland, A. G., Hutchison, J. D., & Alexander, D. A. (2001). C-reactive protein and interleukin-6 receptor in post-traumatic stress disorder: A pilot study. Cytokine, 13(4), 253–255.
59. Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G., & PRISMA Group. (2010). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery, 8(5), 336–341.
60. Monteleone, P., Catapano, F., Fabrazzo, M., Tortorella, A., & Maj, M. (1998). Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology, 37(4), 182–185.
61. Newton, T. L., Fernandez-Botran, R., Miller, J. J., & Burns, V. E. (2014). Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder: Associations with lifetime diagnostic status and psychological context. Biological Psychology, 99, 150–159.
62. O'Donovan, A., Chao, L. L., Paulson, J., Samuelson, K. W., Shigenaga, J. K., Grunfeld, C., … Neylan, T. C. (2015). Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans. Psychoneuroendocrinology, 51, 557–566.
63. O'Donovan, A., Hughes, B. M., Slavich, G. M., Lynch, L., Cronin, M. T., O'Farrelly, C., & Malone, K. M. (2010). Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion–biology relationships. Brain, Behavior, and Immunity, 24(7), 1074–1077.
64. Oganesyan, L. P., Mkrtchyan, G. M., Sukiasyan, S. H., & Boyajyan, A. S. (2009). Classic and alternative complement cascades in post-traumatic stress disorder. Bulletin of Experimental Biology and Medicine, 148(6), 859–861.
65. O'Toole, M. S., Bovbjerg, D. H., Renna, M. E., Lekander, M., Mennin, D. S., & Zachariae, R. (2018). Effects of psychological interventions on systemic levels of inflammatory biomarkers in humans: A systematic review and meta-analysis. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2018.04.005
66. O'Toole, M. S., Zachariae, R., Renna, M. E., Mennin, D. S., & Applebaum, A. (2016). Cognitive behavioral therapies for informal caregivers of patients with cancer and cancer survivors: A systematic review and meta-analysis. Psychooncology, 26(4), 428–437.
67. Passos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., … Kauer-Sant'Anna, M. (2015). Inflammatory markers in post-traumatic stress disorder: A systematic review, meta-analysis, and meta-regression. The Lancet Psychiatry, 2(11), 1002–1012.
68. Pedersen, B. K. (2017). Anti-inflammatory effects of exercise: Role in diabetes and cardiovascular disease. European Journal of Clinical Investigation, 47(8), 600–611.
69. Rapaport, M. H., & Stein, M. B. (1994a). Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia. Anxiety, 1(2), 50–53.
70. Rapaport, M. H., & Stein, M. B. (1994b). Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder. Anxiety, 1(1), 22–25.
71. Rosenthal, R. (1979). The file drawer problem and tolerance for null results. Psychological Bulletin, 86(3), 638–641.
72. Rosenthal, R. (1991). Meta-analysis: A review. Psychosomatic Medicine, 53(3), 247–271.
73. Ryan, G. B., & Majno, G. (1977). Acute inflammation. A review. The American Journal of Pathology, 86(1), 183–276.
74. Sapolsky, R. M. (1994). Why zebras don't get ulcers. New York, NY: WH Freeman.
75. Sareen, J., Jacobi, F., Cox, B. J., Belik, S. L., Clara, I., & Stein, M. B. (2006). Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Archives of Internal Medicine, 166(19), 2109–2116.
76. Schiepers, O. J., Wichers, M. C., & Maes, M. (2005). Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(2), 201–217.
77. Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin, 130(4), 601–630.
78. Slavich, G. M. (2015). Understanding inflammation, its regulation, and relevance for health: A top scientific and public priority. Brain, Behavior, and Immunity, 45, 13–14.
79. Söndergaard, H. P., Hansson, L. O., & Theorell, T. (2004). The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clinica chimica acta, 342(1), 93–98.
80. Song, Y., Zhou, D., Guan, Z., & Wang, X. (2007). Disturbance of serum interleukin-2 and interleukin-8 levels in posttraumatic and non-posttraumatic stress disorder earthquake survivors in northern China. Neuroimmunomodulation, 14(5), 248–254.
81. Sowislo, J. F., & Orth, U. (2013). Does low self-esteem predict depression and anxiety? A meta-analysis of longitudinal studies. Psychological Bulletin, 139(1), 213–240.
82. Spivak, B., Shohat, B., Mester, R., Avraham, S., Gil-Ad, I., Bleich, A., … Weizman, A. (1997). Elevated levels of serum interleukin-1β in combat-related posttraumatic stress disorder. Biological Psychiatry, 42(5), 345–348.
83. Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Vives, A. H., & Cleare, A. J. (2015). Inflammation and clinical response to treatment in depression: A meta-analysis. European Neuropsychopharmacology, 25(10), 1532–1543.
84. Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010). A meta-analysis of cytokines in Alzheimer's disease. Biological Psychiatry, 68(10), 930–941.
85. Tucker, P., Ruwe, W. D., Masters, B., Parker, D. E., Hossain, A., Trautman, R. P., & Wyatt, D. B. (2004). Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biological Psychiatry, 56(2), 121–128.
86. Tükel, R., Arslan, B. A., Ertekin, B. A., Ertekin, E., Oflaz, S., Ergen, A., … İsbir, T. (2012). Decreased IFN-γ and IL-12 levels in panic disorder. Journal of Psychosomatic Research, 73(1), 63–67.
87. Turner, S. M., Beidel, D. C., & Stanley, M. A. (1992). Are obsessional thoughts and worry different cognitive phenomena? Clinical Psychology Review, 12(2), 257–270.
88. Vieira, M. M., Ferreira, T. B., Pacheco, P. A., Barros, P. O., Almeida, C. R., Araújo-Lima, C. F., … Andrade, A. F. (2010). Enhanced Th17 phenotype in individuals with generalized anxiety disorder. Journal of Neuroimmunology, 229(1), 212–218.
89. Vogelzangs, N., Beekman, A. T. F., De Jonge, P., & Penninx, B. W. J. H. (2013). Anxiety disorders and inflammation in a large adult cohort. Translational psychiatry, 3(4), e249.
90. von Känel, R., Hepp, U., Kraemer, B., Traber, R., Keel, M., Mica, L., & Schnyder, U. (2007). Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. Journal of Psychiatric Research, 41(9), 744–752.
91. Wagner, E. Y. N., Wagner, J. T., Glaus, J., Vandeleur, C. L., Castelao, E., Strippoli, M. P. F., … von Känel, R. (2015). Evidence for chronic low-grade systemic inflammation in individuals with agoraphobia from a population-based prospective study. PloS One, 10(4), e0123757.
92. Weiss, N. H., Tull, M. T., Anestis, M. D., & Gratz, K. L. (2013). The relative and unique contributions of emotion dysregulation and impulsivity to posttraumatic stress disorder among substance dependent inpatients. Drug & Alcohol Dependence, 128(1), 45–51.
93. Weizman, R., Laor, N., Barber, Y., Hermesh, H., Notti, I., Djaldetti, M., & Bessler, H. (1996). Cytokine production in obsessive-compulsive disorder. Biological Psychiatry, 40(9), 908–912.
94. Weizman, R., Laor, N., Wiener, Z., Wolmer, L., & Bessler, H. (1999). Cytokine production in panic disorder patients. Clinical Neuropharmacology, 22(2), 107–109.